Update on surgical treatment for endometrial cancer

References

• American Cancer Society Cancer Facts and Figures 2004. American Cancer Society, GA, USA (2004).
   Google Scholar
• No authors listed. Classification and staging of malignant tumours in the female pelvis. Acta Obstet. Gynecol. Scand.50(1), 1–7 (1971).
   PubMedGoogle Scholar
• Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical Stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol.40(1), 55–65 (1991).
   PubMed Web of Science ®Google Scholar
• Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer60(8 Suppl.), 2035–2041 (1987).
   PubMed Web of Science ®Google Scholar
• Federation of Gynecology and Obstetrics. Corpus cancer staging. Int. J. Gynecol. Obstet.28, 190 (1989).
   PubMedGoogle Scholar
• Chan JK, Lin YG, Monk BJ, Tewari K, Bloss JD, Berman ML. Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet. Gynecol.97(5 Pt 1), 707–711 (2001).
   PubMedGoogle Scholar
• Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol. Oncol.38(1), 46–48 (1990).
   PubMed Web of Science ®Google Scholar
• Franchi M, Ghezzi F, Melpignano M et al. Clinical value of intraoperative gross examination in endometrial cancer. Gynecol. Oncol.76(3), 357–361 (2000).
   PubMedGoogle Scholar
• Altintas A, Cosar E, Vardar MA, Demir C, Tuncer I. Intraoperative assessment of depth of myometrial invasion in endometrial carcinoma. Eur. J. Gynecol. Oncol.20(4), 329–331 (1999).
   PubMedGoogle Scholar
• Doering DL, Barnhill DR, Weiser EB, Burke TW, Woodward JE, Park RC. Intraoperative evaluation of depth of myometrial invasion in Stage I endometrial adenocarcinoma. Obstet. Gynecol.74(6), 930–933 (1989).
   PubMedGoogle Scholar
• Barakat RR, Grigsby PW, Sabbatini P, Zaino RJ. Corpus-epithelial tumors. In: Principles and Practice of Gynecologic Oncology. Hoskins WJ, Perez CA, Young RC (Eds), Lippincott-Raven, PA, USA, 919–953 (1997).
   Google Scholar
• Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet. Gynecol.86(1), 38–42 (1995).
   PubMed Web of Science ®Google Scholar
• Obermair A, Geramou M, Gucer F et al. Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int. J. Gynecol. Cancer9(5), 383–386 (1999).
   PubMed Web of Science ®Google Scholar
• Creutzberg CL, van Putten WL, Koper PC et al. Surgery and postoperative radiotherapy versus surgery alone for patients with Stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post operative radiation therapy in endometrial carcinoma. Lancet355(9213), 1404–1411 (2000).
   PubMed Web of Science ®Google Scholar
• Keys HM, Roberts JA, Brunetto VL et al. A Phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol. Oncol.92(3), 744–751 (2004).
   PubMed Web of Science ®Google Scholar
• Barnes MN, Roland PY, Straughn M et al. A comparison of treatment strategies for endometrial adenocarcinoma: analysis of financial impact. Gynecol. Oncol.74(3), 443–447 (1999).
   PubMed Web of Science ®Google Scholar
• Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer91(2), 378–387 (2001).
   PubMed Web of Science ®Google Scholar
• Homesley HD, Boike G, Spiegel GW. Feasibility of laparoscopic management of presumed Stage I endometrial carcinoma and assessment of accuracy of myoinvasion estimates by frozen section: a Gynecologic Oncology Group study. Int. J. Gynecol. Cancer14(2), 341–347 (2004).
   PubMed Web of Science ®Google Scholar
• Kohler C, Klemm P, Schau A et al. Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. Gynecol. Oncol.95(1), 52–61 (2004).
   PubMed Web of Science ®Google Scholar
• Magrina JF, Mutone NF, Weaver AL, Magtibay PM, Fowler RS, Cornella JL. Laparoscopic lymphadenectomy and vaginal or laparoscopic hysterectomy with bilateral salpingo-oophorectomy for endometrial cancer: morbidity and survival. Am. J. Obstet. Gynecol.181(2), 376–381 (1999).
   PubMed Web of Science ®Google Scholar
• Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol. Oncol.92(3), 789–793 (2004).
   PubMed Web of Science ®Google Scholar
• Gemignani ML, Curtin JP, Zelmanovich J, Patel DA, Venkatraman E, Barakat RR. Laparoscopic-assisted vaginal hysterectomy for endometrial cancer: clinical outcomes and hospital charges. Gynecol. Oncol.73(1), 5–11 (1999).
   PubMed Web of Science ®Google Scholar
• Malur S, Possover M, Schneider A. Laparoscopically assisted radical vaginal versus radical abdominal hysterectomy Type II in patients with cervical cancer. Surg. Endosc.15(3), 289–292 (2001).
   PubMedGoogle Scholar
• Fram KM. Laparoscopically assisted vaginal hysterectomy versus abdominal hysterectomy in Stage I endometrial cancer. Int. J. Gynecol. Cancer12(1), 57–61 (2002).
   PubMedGoogle Scholar
• Scribner DR Jr, Mannel RS, Walker JL, Johnson GA. Cost analysis of laparoscopy versus laparotomy for early endometrial cancer. Gynecol. Oncol.75(3), 460–463 (1999).
   PubMedGoogle Scholar
• Eltabbakh GH. Analysis of survival after laparoscopy in women with endometrial carcinoma. Cancer95(9), 1894–1901 (2002).
   PubMed Web of Science ®Google Scholar
• Magrina JF, Weaver AL. Laparoscopic treatment of endometrial cancer: five-year recurrence and survival rates. Eur. J. Gynecol. Oncol.25(4), 439–441 (2004).
   PubMedGoogle Scholar
• Scribner DR Jr, Walker JL, Johnson GA, McMeekin DS, Gold MA, Mannel RS. Laparoscopic pelvic and paraaortic lymph node dissection in the obese. Gynecol. Oncol.84(3), 426–430 (2002).
   PubMedGoogle Scholar
• Scribner DR Jr, Walker JL, Johnson GA, McMeekin SD, Gold MA, Mannel RS. Surgical management of early-stage endometrial cancer in the elderly: is laparoscopy feasible? Gynecol. Oncol.83(3), 563–568 (2001).
   PubMed Web of Science ®Google Scholar
• Sonoda Y, Zerbe M, Smith A, Lin O, Barakat RR, Hoskins WJ. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol. Oncol.80(3), 378–382 (2001).
   PubMedGoogle Scholar
• Vergote I, De Smet I, Amant F. Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy. Gynecol. Oncol.84(3), 537–538 (2002).
   PubMedGoogle Scholar
• Sonoda Y, Luken DW, Chi D et al. The significance of positive peritoneal cytology in clinical early-stage endometrial cancer patients treated by laparoscopically assisted vaginal hysterectomy. Proc. Soc. Gynecol. Oncol.(2001) (Abstract 1209).
   Google Scholar
• Takeshima N, Hirai Y, Yano K, Tanaka N, Yamauchi K, Hasumi K. Ovarian metastasis in endometrial carcinoma. Gynecol. Oncol.70(2), 183–187 (1998).
   PubMed Web of Science ®Google Scholar
• Connell PP, Rotmensch J, Waggoner S, Mundt AJ. The significance of adnexal involvement in endometrial carcinoma. Gynecol. Oncol.74(1), 74–79 (1999).
   PubMedGoogle Scholar
• Onda T, Yoshikawa H, Mizutani K et al. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br. J. Cancer75(12), 1836–1841 (1997).
   PubMed Web of Science ®Google Scholar
• Mariani A, Webb MJ, Galli L, Podratz KC. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol. Oncol.76(3), 348–356 (2000).
   PubMed Web of Science ®Google Scholar
• Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol.56(1), 29–33 (1995).
   PubMed Web of Science ®Google Scholar
• Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ. FIGO Stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer13(5), 664–672 (2003).
   PubMedGoogle Scholar
• Aalders JG, Abeler V, Kolstad P. Clinical (Stage III) as compared to subclinical intrapelvic extrauterine tumor spread in endometrial carcinoma: a clinical and histopathological study of 175 patients. Gynecol. Oncol.17(1), 64–74 (1984).
   PubMed Web of Science ®Google Scholar
• Nicklin JL, Petersen RW. Stage 3B adenocarcinoma of the endometrium: a clinicopathologic study. Gynecol. Oncol.78(2), 203–207 (2000).
   PubMedGoogle Scholar
• Society of Gynecologic Oncologists Medical Practice Committee. Practice guidelines: uterine corpus-endometrial cancer. Society of Gynecologic Oncologists Medical Practice Committee. Oncology (Huntingt).12(1), 122–126 (1998).
   PubMedGoogle Scholar
• Mackillop WJ, Pringle JF. Stage III endometrial carcinoma. A review of 90 cases. Cancer56(10), 2519–2523 (1985).
   PubMedGoogle Scholar
• Danoff BF, McDay J, Louka M, Lewis GC, Lee J, Kramer S. Stage III endometrial carcinoma: analysis of patterns of failure and therapeutic implications. Int. J. Radiat. Oncol. Biol. Phys.6(11), 1491–1495 (1980).
   PubMed Web of Science ®Google Scholar
• Genest P, Drouin P, Girard A, Gerig L. Stage III carcinoma of the endometrium: a review of 41 cases. Gynecol. Oncol.26(1), 77–86 (1987).
   PubMed Web of Science ®Google Scholar
• Bruckman JE, Bloomer WD, Marck A, Ehrmann RL, Knapp RC. Stage III adenocarcinoma of the endometrium: two prognostic groups. Gynecol. Oncol.9(1), 12–17 (1980).
   PubMed Web of Science ®Google Scholar
• Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol. Oncol.17(1), 85–103 (1984).
   PubMed Web of Science ®Google Scholar
• Goff BA, Goodman A, Muntz HG, Fuller AF Jr, Nikrui N, Rice LW. Surgical Stage IV endometrial carcinoma: a study of 47 cases. Gynecol. Oncol.52(2), 237–240 (1994).
   PubMed Web of Science ®Google Scholar
• Lambrou NC, Gomez-Marin O, Mirhashemi R et al. Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol. Oncol.93(3), 653–658 (2004).
   PubMed Web of Science ®Google Scholar
• Chi DS, Welshinger M, Venkatraman ES, Barakat RR. The role of surgical cytoreduction in Stage IV endometrial carcinoma. Gynecol. Oncol.67(1), 56–60 (1997).
   PubMed Web of Science ®Google Scholar
• Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ. Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol. Oncol.78(2), 85–91 (2000).
   PubMed Web of Science ®Google Scholar
• Reddoch JM, Burke TW, Morris M, Tornos C, Levenback C, Gershenson DM. Surveillance for recurrent endometrial carcinoma: development of a follow-up scheme. Gynecol. Oncol.59(2), 221–225 (1995).
   PubMedGoogle Scholar
• Kuten A, Grigsby PW, Perez CA, Fineberg B, Garcia DM, Simpson JR. Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients. Int. J. Radiat. Oncol. Biol. Phys.17(1), 29–34 (1989).
   PubMedGoogle Scholar
• Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma: a one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer1, 1777 (1948).
   Google Scholar
• Chi DS, Gemignani ML, Curtin JP, Hoskins WJ. Long-term experience in the surgical management of cancer of the uterine cervix. Semin. Surg. Oncol.17(3), 161–167 (1999).
   PubMedGoogle Scholar
• Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol. Oncol.60(2), 288–291 (1996).
   PubMed Web of Science ®Google Scholar
• Barakat RR, Goldman NA, Patel DA, Venkatraman ES, Curtin JP. Pelvic exenteration for recurrent endometrial cancer. Gynecol. Oncol.75(1), 99–102 (1999).
   PubMed Web of Science ®Google Scholar
• Garton GR, Gunderson LL, Webb MJ et al. Intraoperative radiation therapy in gynecologic cancer: the Mayo Clinic experience. Gynecol. Oncol.48(3), 328–332 (1993).
   PubMed Web of Science ®Google Scholar
• Garton GR, Gunderson LL, Webb MJ, Wilson TO, Cha SS, Podratz KC. Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution. Int. J. Radiat. Oncol. Biol. Phys.37(4), 839–843 (1997).
   PubMedGoogle Scholar
• Haddock MG, Petersen IA, Webb MJ, Wilson TO, Podratz KC, Gunderson LL. IORT for locally advanced gynecological malignancies. Front. Radiat. Ther. Oncol.31, 256–259 (1997).
   PubMedGoogle Scholar
• Gemignani ML, Alektiar KM, Leitao M et al. Radical surgical resection and high-dose intraoperative radiation therapy (HDR-IORT) in patients with recurrent gynecologic cancers. Int. J. Radiat. Oncol. Biol. Phys.50(3), 687–694 (2001).
   PubMedGoogle Scholar
• Campagnutta E, Giorda G, De Piero G et al. Surgical treatment of recurrent endometrial carcinoma. Cancer100(1), 89–96 (2004).
   PubMed Web of Science ®Google Scholar